Popular Articles

Supporting New Biotechs Using Incubator Network Created At Mission Bay
The California Institute of Quantitative Biosciences (QB3) has joined with the City of San Francisco and FibroGen Inc to launch the QB3 Mission Bay Incubator Network, to spur growth in the bioscience industry.
drugs without prescription
US To Start Human Trials Of H1N1 Swine Flu Vaccine In August
The United States will start human trials of an experimental vaccine for preventing the 2009 H1N1 influenza virus in August; the first
News of the day
Shire Announces Study Results Of The Effects Of INTUNIV™ Extended Release On Secondary Measures In Children With ADHD And Oppositional Symptoms
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced new findings on INTUNIV (guanfacine) extended release, a selective alpha-2A-agonist, at a major psychiatric meeting. This randomized placebo controlled trial met its primary objective, which was to evaluate the effects of INTUNIV on oppositional symptoms in children aged 6 to 12 years with a diagnosis of ADHD and the presence of oppositional symptoms. The data presented today on this investigational compound reviewed secondary efficacy measures from three different rating scales.
Mental Health

Also In Global Health News: Children With HIV/AIDS; Leishmaniasis Treatment; ITNs In Tanzania; U.S. Malaria Fight; PEPFAR Safe Injection Funds

IRIN Examines Hardships Facing Parents, Guardians Of Children Living With HIV/AIDS IRIN examines the hardships parents and guardians of the estimated 170,000 Kenyan children currently infected with HIV often face. "Caregivers face the dilemma of how to disclose status to ... [HIV-positive] children, and to whom," as well as other issues, Mabel Ngoe Takona, HIV/AIDS Coordinator for Africa at ActionAid, said. The article explores ways the government could help to provide parents and guardians with disclosure guidelines as well as training and support (IRIN, 6/24). University Of Dundee , DNDi Working Together To Develop Leishmaniasis Treatments The University of Dundee"s drug discovery unit is working with the Drugs for Neglected Diseases initiative on a potential five-year 1.8 million pound - about $3 million - deal to develop "affordable and effective" treatments for visceral leishmaniasis, PharmaTimes reports. The money provided under the partnership will be put towards establishing a dedicated leishmaniasis drug discovery group at the university (McKee, PharmaTimes, 6/23). Campaign Under Way To Distribute 7.2M Mosquito Nets To Children Under 5 In Tanzania The Citizen examines the Tanzanian government"s efforts to rid the country of malaria. In an address to the Parliament on Monday, Aisha Kigoda, the deputy minister for Health and Social Welfare, spoke of a campaign underway that aims to distribute 7.2 million mosquito nets countrywide to children under the age of five. So far, 962,312 mosquito nets have been distributed (Said/Jube, Citizen, 6/23). BMJ Examines U.S. Role In Fighting Malaria The British Medical Journal examines the U.S. role in fighting malaria worldwide. According to BMJ, "[b]ilateral US funding for malaria has grown almost fourfold, from $198 million in 2004 to a projected $762 million in 2010." Timothy Ziemer, head of the President"s Malaria Initiative, said, "We"ve gotten past the slogans and rhetoric" on malaria, and the U.S. is focusing on what works, expanding successes and on strengthening local health systems sustain efforts (Roehr, BMJ, 6/22). The article quotes experts from the Kaiser Family Foundation"s recent briefing, which examined the U.S. government"s role in addressing malaria moving forward, including its strategic options for reducing the impact of the disease, and the current status of the development of the comprehensive malaria strategy. A webcast, transcript and other res are available here. PEPFAR Funds Supplies, Training To Promote Safe Injection Practices Over the past five years, PEPFAR has helped to purchase and distribute over 7 million safe injection commodities and train over 10,000 health workers through the Making Medical Injections Safer (MMIS) project in Nigeria, Vanguard/allAfrica.com reports. Speaking in Lagos last week, MMIS Country Director Abimbola Sowande "[c]ommend[ed] Lagos state government for blazing the trail in injection safety" and "called on other states in Nigeria to copy the best practices currently apply in the state," Vanguard/allAfrica.com writes (Obinna, Vanguard/allAfrica.com, 6/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):